{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:43:08Z","timestamp":1787002988483,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The molecular mechanisms induced by hypoxia are misunderstood in non-small cell lung cancer (NSCLC), and above all the hypoxia and RASSF1A\/Hippo signaling relationship. We confirmed that human NSCLC (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200945) as their brain metastases (BM) counterpart are hypoxic since positive with CAIX-antibody (target gene of Hypoxia-inducible factor (HIF)). A severe and prolonged hypoxia (0.2% O2, 48\u2009h) activated YAP (but not TAZ) in Human Bronchial Epithelial Cells (HBEC) lines by downregulating RASSF1A\/kinases Hippo (except for NDR2) regardless their promoter methylation status. Subsequently, the NDR2-overactived HBEC cells exacerbated a HIF-1A, YAP and C-Jun-dependent-amoeboid migration, and mainly, support BM formation. Indeed, NDR2 is more expressed in human tumor of metastatic NSCLC than in human localized NSCLC while NDR2 silencing in HBEC lines (by shRNA) prevented the xenograft formation and growth in a lung cancer-derived BM model in mice. Collectively, our results indicated that NDR2 kinase is over-active in NSCLC by hypoxia and supports BM formation. NDR2 expression is thus a useful biomarker to predict the metastases risk in patients with NSCLC, easily measurable routinely by immunohistochemistry on tumor specimens.\n                  <\/jats:p>","DOI":"10.1038\/s41419-023-06345-3","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T13:03:00Z","timestamp":1702472580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell Lung Cancer"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4133-2813","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Levallet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Biojout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bazille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Douy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1148-7497","authenticated-orcid":false,"given":"Fat\u00e9m\u00e9h","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri Leite","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Teulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Toutain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Elie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Bernaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-0270","authenticated-orcid":false,"given":"Samuel","family":"Valable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Bergot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7772-0581","authenticated-orcid":false,"given":"Gu\u00e9na\u00eblle","family":"Levallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,13]]},"reference":[{"key":"6345_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.tips.2017.10.009","volume":"39","author":"Q Chen","year":"2018","unstructured":"Chen Q, Liu G, Liu S, Su H, Wang Y, Li J, et al. Remodeling the tumour microenvironment with emerging nanotherapeutics. Trends Pharmacol Sci. 2018;39:59\u201374.","journal-title":"Trends Pharmacol Sci"},{"key":"6345_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jnci\/djx160","volume":"110","author":"A Salem","year":"2018","unstructured":"Salem A, Asselin MC, Reymen B, Jackson A, Lambin P, West CML, et al. Targeting hypoxia to improve non-small cell lung cancer outcome. J Natl Cancer Inst. 2018;110:14\u201330.","journal-title":"J Natl Cancer Inst"},{"key":"6345_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/cells10010141","volume":"10","author":"I Zi\u00f3\u0142kowska-Suchanek","year":"2021","unstructured":"Zi\u00f3\u0142kowska-Suchanek I. Mimicking tumour hypoxia in non-small cell lung cancer employing three-dimensional in vitro models. Cell. 2021;10:141\u201364.","journal-title":"Cell"},{"key":"6345_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.molcel.2009.10.009","volume":"36","author":"RK Palakurthy","year":"2009","unstructured":"Palakurthy RK, Wajapeyee N, Santra MK, Gazin C, Lin L, Gobeil S, et al. Epigenetic silencing of the RASSF1A tumour suppressor gene through HOXB3-mediated induction of DNMT3B expression. Mol Cell. 2009;36:219\u201330.","journal-title":"Mol Cell"},{"key":"6345_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.abb.2014.07.024","volume":"562","author":"L Yan","year":"2014","unstructured":"Yan L, Cai Q, Xu Y. Hypoxic conditions differentially regulate TAZ and YAP in cancer cells. Arch Biochem Biophys. 2014;562:31\u201336.","journal-title":"Arch Biochem Biophys"},{"key":"6345_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ncb3073","volume":"17","author":"B Ma","year":"2015","unstructured":"Ma B, Chen Y, Chen L, Cheng H, Mu C, Li J, et al. Hypoxia regulates hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat Cell Biol. 2015;17:95\u2013103.","journal-title":"Nat Cell Biol"},{"key":"6345_CR7","doi-asserted-by":"publisher","first-page":"11123","DOI":"10.1038\/ncomms11123","volume":"7","author":"B Ma","year":"2016","unstructured":"Ma B, Cheng H, Gao R, Mu C, Chen L, Wu S, et al. Zyxin-Siah2-Lats2 axis mediates cooperation between hippo and TGF-\u03b2 signalling pathways. Nat Commun. 2016;7:11123\u201336.","journal-title":"Nat Commun"},{"key":"6345_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature19081","volume":"537","author":"B Thienpont","year":"2016","unstructured":"Thienpont B, Steinbacher J, Zhao H, D\u2019Anna F, Kuchnio A, Ploumakis A, et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature. 2016;537:63\u201368.","journal-title":"Nature"},{"key":"6345_CR9","doi-asserted-by":"publisher","first-page":"101042831769168","DOI":"10.1177\/1010428317691684","volume":"39","author":"H Wei","year":"2017","unstructured":"Wei H, Xu Z, Liuv F, Wang F, Wang X, Sun X, et al. Hypoxia induces oncogene yes-associated protein 1 nuclear translocation to promote pancreatic ductal adenocarcinoma invasion via epithelial\u2013mesenchymal transition. Tumour Biol. 2017;39:1010428317691684.","journal-title":"Tumour Biol"},{"key":"6345_CR10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.apsb.2019.12.010","volume":"10","author":"C Zhao","year":"2020","unstructured":"Zhao C, Zeng C, Ye S, Dai X, He Q, Yang B, et al. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer. Acta Pharm Sin B. 2020;10:947\u201360.","journal-title":"Acta Pharm Sin B"},{"key":"6345_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13046-018-0892-2","volume":"37","author":"X Zhang","year":"2018","unstructured":"Zhang X, Li Y, Ma Y, Yang L, Wang T, Meng X, et al. Yes-associated protein (YAP) binds to HIF-1\u03b1 and sustains HIF-1\u03b1 protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress. J Exp Clin Cancer Res. 2018;37:216\u201328.","journal-title":"J Exp Clin Cancer Res"},{"key":"6345_CR12","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.1074\/jbc.M117.805655","volume":"292","author":"X Ma","year":"2017","unstructured":"Ma X, Zhang H, Xue X, Shah YM. Hypoxia-inducible factor 2\u03b1 (HIF-2\u03b1) promotes colon cancer growth by potentiating yes-associated protein 1 (YAP1) activity. J Biol Chem. 2017;292:17046\u201356.","journal-title":"J Biol Chem"},{"key":"6345_CR13","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1158\/1078-0432.CCR-11-2797","volume":"18","author":"F de Fraipont","year":"2012","unstructured":"de Fraipont F, Levallet G, Creveuil C, Bergot E, Beau-Faller M, Mounawar M, et al. An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial. Clin Cancer Res. 2012;18:2976\u201386.","journal-title":"Clin Cancer Res"},{"key":"6345_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13046-019-1145-8","volume":"38","author":"M Keller","year":"2019","unstructured":"Keller M, Dubois F, Teulier S, Martin APJ, Levallet J, Maille E, et al. NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells. J Exp Clin Cancer Res. 2019;38:158\u201374.","journal-title":"J Exp Clin Cancer Res"},{"key":"6345_CR15","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1158\/0008-5472.CAN-15-1008","volume":"76","author":"F Dubois","year":"2016","unstructured":"Dubois F, Keller M, Calvayrac O, Soncin F, Hoa L, Hergovich A, et al. RASSF1A suppresses the invasion and metastatic potential of human non-small cell lung cancer cells by inhibiting YAP activation through the GEF-H1\/RhoB pathway \u00bb. Cancer Res. 2016;76:1627\u201340.","journal-title":"Cancer Res"},{"key":"6345_CR16","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1038\/s41467-019-10044-z","volume":"10","author":"S Dabral","year":"2019","unstructured":"Dabral S, Muecke C, Valasarajan C, Schmoranzer M, Wietelmann A, Semenza GL, et al. A RASSF1A-HIF1\u03b1 loop drives Warburg effect in cancer and pulmonary hypertension. Nat Commun. 2019;10:2130\u201348.","journal-title":"Nat Commun"},{"key":"6345_CR17","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1158\/1078-0432.CCR-05-2049","volume":"12","author":"QT Le","year":"2006","unstructured":"Le QT, Chen E, Salim A, Cao H, Kong CS, Whyte R, et al. An evaluation of tumour oxygenation and gene expression in patients with early stage non small cell lung cancers. Clin Cancer Res. 2006;12:1507\u201314.","journal-title":"Clin Cancer Res"},{"key":"6345_CR18","doi-asserted-by":"publisher","first-page":"20130676","DOI":"10.1259\/bjr.20130676","volume":"87","author":"SR McKeown","year":"2014","unstructured":"McKeown SR. Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol. 2014;87:20130676.","journal-title":"Br J Radiol"},{"key":"6345_CR19","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1582-4934.2011.01258.x","volume":"15","author":"A Carreau","year":"2011","unstructured":"Carreau A, El Hafny-Rahbiv B, Matejuk A, Grillon C, Kieda C. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med. 2011;15:1239\u201353.","journal-title":"J Cell Mol Med"},{"key":"6345_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-90662-0","volume":"11","author":"A Corroyer-Dulmont","year":"2021","unstructured":"Corroyer-Dulmont A, Valable S, Fantin J, Chatre L, Toutain J, Teulier S, et al. Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy. Sci Rep. 2021;11:11239.","journal-title":"Sci Rep"},{"key":"6345_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1\u201317.","journal-title":"Genes Dev"},{"key":"6345_CR22","doi-asserted-by":"publisher","first-page":"88437","DOI":"10.18632\/oncotarget.18177","volume":"8","author":"AP Jim\u00e9nez","year":"2017","unstructured":"Jim\u00e9nez AP, Traum A, Boettger T, Hackstein H, Richter AM, Dammann RH. The tumour suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumour growth. Oncotarget. 2017;8:88437\u201352.","journal-title":"Oncotarget"},{"key":"6345_CR23","doi-asserted-by":"publisher","first-page":"616","DOI":"10.2174\/138161282205160127095338","volume":"22","author":"MA Ashaie","year":"2016","unstructured":"Ashaie MA, Chowdhury EH. Cadherins: the superfamily critically involved in breast cancer. Curr Pharm Des. 2016;22:616\u201338.","journal-title":"Curr Pharm Des"},{"key":"6345_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07167-0","volume":"9","author":"M Kotini","year":"2018","unstructured":"Kotini M, Barriga EH, Leslie J, Gentzel M, Rauschenberger V, Schambony A, et al. Gap Junction protein connexin-43 is a direct transcriptional regulator of N-cadherin in vivo. Nat Commun. 2018;9:4633.","journal-title":"Nat Commun"},{"key":"6345_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/gtc.12671","volume":"24","author":"M Tanaka","year":"2019","unstructured":"Tanaka M, Fujii Y, Hirano K, Higaki T, Nagasaki A, Ishikawa R, et al. Fascin in lamellipodia contributes to cell elasticity by controlling the orientation of filamentous actin. Genes Cells. 2019;24:202\u201313.","journal-title":"Genes Cells"},{"key":"6345_CR26","doi-asserted-by":"publisher","first-page":"0210051","DOI":"10.1115\/1.4035121","volume":"139","author":"M Lintz","year":"2017","unstructured":"Lintz M, Mu\u00f1oz A, Reinhart-King CA. The mechanics of single cell and collective migration of tumour cells. J Biomech Eng. 2017;139:0210051\u20139.","journal-title":"J Biomech Eng"},{"key":"6345_CR27","doi-asserted-by":"publisher","first-page":"44498","DOI":"10.18632\/oncotarget.17806","volume":"8","author":"E T\u00e1trai","year":"2017","unstructured":"T\u00e1trai E, Bartal A, Gacs A, Paku S, Kenessey I, Garay T, et al. Cell type-dependent HIF1 \u03b1-mediated effects of hypoxia on proliferation, migration and metastatic potential of human tumour cells. Oncotarget. 2017;8:44498\u2013510.","journal-title":"Oncotarget"},{"key":"6345_CR28","first-page":"7075","volume":"60","author":"CC Wykoff","year":"2000","unstructured":"Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, et al. Hypoxia-inducible expression of tumour-associated carbonic anhydrases. Cancer Res. 2000;60:7075\u201383.","journal-title":"Cancer Res"},{"key":"6345_CR29","doi-asserted-by":"publisher","first-page":"R678","DOI":"10.1016\/S0960-9822(03)00607-9","volume":"13","author":"R Grose","year":"2003","unstructured":"Grose R. Epithelial migration: open your eyes to c-Jun. Curr Biol. 2003;13:R678\u2013R680.","journal-title":"Curr Biol"},{"key":"6345_CR30","doi-asserted-by":"publisher","first-page":"C367","DOI":"10.1152\/ajpcell.00330.2016","volume":"312","author":"PY Wang","year":"2017","unstructured":"Wang PY, Wang SR, Xiao L, Chen J, Wang JY, Rao JN, et al. c-Jun enhances intestinal epithelial restitution after wounding by increasing phospholipase C-\u03b31 transcription. Am J Physiol Cell Physiol. 2017;312:C367\u2013C375.","journal-title":"Am J Physiol Cell Physiol"},{"key":"6345_CR31","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.2147\/OTT.S162700","volume":"11","author":"G Lin","year":"2018","unstructured":"Lin G, Yu B, Liang Z, Li L, Qu S, Chen K, et al. Silencing of c-jun decreases cell migration, invasion, and EMT in radioresistant human nasopharyngeal carcinoma cell line CNE-2R. Onco Targets Ther. 2018;11:3805\u201315.","journal-title":"Onco Targets Ther"},{"key":"6345_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1128\/MCB.22.1.12-22.2002","volume":"22","author":"A Alfranca","year":"2002","unstructured":"Alfranca A, Guti\u00e9rrez MD, Vara A, Aragon\u00e9s J, Vidal F, Land\u00e1zuri MO. c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. Mol Cell Biol. 2002;22:12\u201322.","journal-title":"Mol Cell Biol"},{"key":"6345_CR33","doi-asserted-by":"publisher","first-page":"7704","DOI":"10.1158\/0008-5472.CAN-09-0808","volume":"69","author":"B Yu","year":"2009","unstructured":"Yu B, Miao ZH, Jiang Y, Li MH, Yang N, Li T, et al. c-Jun protects hypoxia-inducible factor-1alpha from degradation via its oxygen-dependent degradation domain in a nontranscriptional manner. Cancer Res. 2009;69:7704\u201312.","journal-title":"Cancer Res"},{"key":"6345_CR34","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1128\/MCB.22.8.2515-2523.2002","volume":"22","author":"KR Laderoute","year":"2002","unstructured":"Laderoute KR, Calaoagan JM, Gustafson-Brown C, Knapp AM, Li GC, Mendonca HL, et al. The response of c-jun\/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent. Mol Cell Biol. 2002;22:2515\u201323.","journal-title":"Mol Cell Biol"},{"key":"6345_CR35","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1158\/0008-5472.CAN-04-2792","volume":"65","author":"YM Whang","year":"2005","unstructured":"Whang YM, Kim YH, Kim J, Yoo YD. RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res. 2005;65:3682\u201390.","journal-title":"Cancer Res"},{"key":"6345_CR36","first-page":"w13855","volume":"143","author":"W Ren","year":"2013","unstructured":"Ren W, Mi D, Yang K, Cao N, Tian J, Li Z, et al. The expression of hypoxia-inducible factor-1\u03b1 and its clinical significance in lung cancer: a systematic review and meta-analysis. Swiss Med Wkly. 2013;143:w13855.","journal-title":"Swiss Med Wkly"},{"key":"6345_CR37","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11596-016-1586-7","volume":"36","author":"SL Yang","year":"2016","unstructured":"Yang SL, Ren QG, Wen L, Hu JL. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis. J Huazhong Univ Sci Technol Med Sci. 2016;36:321\u20137.","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"6345_CR38","doi-asserted-by":"publisher","first-page":"101042831770963","DOI":"10.1177\/1010428317709637","volume":"39","author":"ZJ Gao","year":"2017","unstructured":"Gao ZJ, Wang Y, Yuan W, Yuan JQ, Yuan K. HIF-2\u03b1 not HIF-1\u03b1 overexpression confers poor prognosis in non-small cell lung cancer. Tumour Biol. 2017;39:1010428317709637.","journal-title":"Tumour Biol"},{"key":"6345_CR39","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.7150\/jca.53119","volume":"12","author":"H Zheng","year":"2021","unstructured":"Zheng H, Ning Y, Zhan Y, Liu S, Yang Y, Wen Q, et al. Co-expression of PD-L1 and HIF-1\u03b1 predicts poor prognosis in patients with non-small cell lung cancer after surgery. J Cancer. 2021;12:2065\u201372.","journal-title":"J Cancer"},{"key":"6345_CR40","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.3390\/cancers13143421","volume":"13","author":"J Ancel","year":"2021","unstructured":"Ancel J, Perotin JM, Dewolf M, Launois C, Mulette P, Nawrocki-Raby B, et al. Hypoxia in lung cancer management: a translational approach. Cancers. 2021;13:3421.","journal-title":"Cancers"},{"key":"6345_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/path.2863","volume":"224","author":"VV Polosukhin","year":"2011","unstructured":"Polosukhin VV, Cates JM, Lawson WE, Milstone AP, Matafonov AG, Massion PP, et al. Hypoxia-inducible factor-1 signalling promotes goblet cell hyperplasia in airway epithelium. J Pathol. 2011;224:203\u201311.","journal-title":"J Pathol"},{"key":"6345_CR42","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.ccell.2017.09.007","volume":"32","author":"SS Mello","year":"2017","unstructured":"Mello SS, Valente LJ, Raj N, Seoane JA, Flowers BM, McClendon J, et al. A p53 super-tumor suppressor reveals a tumor suppressive p53-Ptpn14-Yap axis in pancreatic cancer. Cancer Cell. 2017;32:460\u201373.","journal-title":"Cancer Cell"},{"key":"6345_CR43","doi-asserted-by":"publisher","first-page":"e8699","DOI":"10.15252\/emmm.201708699","volume":"10","author":"A Greenhough","year":"2018","unstructured":"Greenhough A, Bagley C, Heesom KJ, Gurevich DB, Gay D, Bond M, et al. Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med. 2018;10:e8699.","journal-title":"EMBO Mol Med"},{"key":"6345_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/cancers10040121","volume":"10","author":"TH Nguyen","year":"2018","unstructured":"Nguyen TH, Kugler JM. Ubiquitin-dependent regulation of the mammalian hippo pathway: therapeutic implications for cancer. Cancers. 2018;10:121.","journal-title":"Cancers"},{"key":"6345_CR45","doi-asserted-by":"publisher","first-page":"10909","DOI":"10.1007\/s13277-016-4934-0","volume":"37","author":"Z Liang","year":"2016","unstructured":"Liang Z, Wang Y, Shen Z, Teng X, Li X, Li C, et al. Fascin 1 promoted the growth and migration of non-small cell lung cancer cells by activating YAP\/TEAD signaling. Tumour Biol. 2016;37:10909\u201315.","journal-title":"Tumour Biol"},{"key":"6345_CR46","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cub.2016.11.057","volume":"27","author":"S Lehmann","year":"2017","unstructured":"Lehmann S, Te Boekhorst V, Odenthal J, Bianchi R, van Helvert S, Ikenberg K, et al. Hypoxia induces a HIF-1-dependent transition from collective-to-amoeboid dissemination in epithelial cancer cells. Curr Biol. 2017;27:392\u2013400.","journal-title":"Curr Biol"},{"key":"6345_CR47","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4103\/jcrt.JCRT_732_17","volume":"14","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liang B, Dong H. Expression of Fascin_1 protein in cancer tissues of patients with nonsmall cell lung cancer and its relevance to patients\u2019 clinicopathologic features and prognosis. J Cancer Res Ther. 2018;14:856\u20139.","journal-title":"J Cancer Res Ther"},{"key":"6345_CR48","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.bbrc.2018.02.134","volume":"497","author":"D Zhao","year":"2018","unstructured":"Zhao D, Zhang T, Hou XM, Ling XL. Knockdown of fascin-1 expression suppresses cell migration and invasion of non-small cell lung cancer by regulating the MAPK pathway. Biochem Biophys Res Commun. 2018;497:694\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"6345_CR49","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-13-3009","volume":"74","author":"X Zhao","year":"2014","unstructured":"Zhao X, Gao S, Ren H, Sun W, Zhang H, Sun J, et al. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin. Cancer Res. 2014;74:2455\u201364.","journal-title":"Cancer Res"},{"key":"6345_CR50","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/carcin\/bgn088","volume":"29","author":"K Salnikow","year":"2008","unstructured":"Salnikow K, Aprelikova O, Ivanov S, Tackett S, Kaczmarek M, Karaczyn A, et al. Regulation of hypoxia-inducible genes by ETS1 transcription factor. Carcinogenesis. 2008;29:1493\u2013509.","journal-title":"Carcinogenesis"},{"key":"6345_CR51","doi-asserted-by":"publisher","first-page":"32126","DOI":"10.1074\/jbc.M113.495218","volume":"288","author":"W Zhang","year":"2013","unstructured":"Zhang W, Zhao J, Lee JF, Gartung A, Jawadi H, Lambiv WL, et al. ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis. J Biol Chem. 2013;288:32126\u201337.","journal-title":"J Biol Chem"},{"key":"6345_CR52","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1073\/pnas.1322484111","volume":"111","author":"HS Leong","year":"2014","unstructured":"Leong HS, Chambers AF. Hypoxia promotes tumor cell motility via RhoA and ROCK1 signaling pathways. Proc Natl Acad Sci USA. 2014;111:887\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6345_CR53","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1074\/jbc.RA118.004364","volume":"294","author":"JM Lamar","year":"2019","unstructured":"Lamar JM, Xiao Y, Norton E, Jiang ZG, Gerhard GM, Kooner S, et al. SRC tyrosine kinase activates the YAP\/TAZ axis and thereby drives tumor growth and metastasis. J Biol Chem. 2019;294:2302\u201317.","journal-title":"J Biol Chem"},{"key":"6345_CR54","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.jmoldx.2019.03.007","volume":"21","author":"G Levallet","year":"2019","unstructured":"Levallet G, Creveuil C, Bekaert L, P\u00e9res E, Planchard G, Lecot-Cotigny S, et al. Promoter hypermethylation of genes encoding for RASSF\/hippo pathway members reveals specific alteration pattern in diffuse gliomas. J Mol Diagn. 2019;21:695\u2013704.","journal-title":"J Mol Diagn"},{"key":"6345_CR55","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1158\/1535-7163.MCT-11-0899","volume":"1","author":"G Levallet","year":"2012","unstructured":"Levallet G, Bergot E, Antoine M, Creveuil C, Santos AO, Beau-Faller M, et al. High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway. Mol Cancer Ther. 2012;1:1203\u201313.","journal-title":"Mol Cancer Ther"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06345-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06345-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06345-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T14:03:06Z","timestamp":1702476186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-06345-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,13]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6345"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-06345-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.03.20.533395","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,13]]},"assertion":[{"value":"27 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Ethics Committee of the Caen University Hospital center (protocol code DC-2008-588, date of approval: 12 April 2010) authorizing the collection, conservation and preparation activities for scientific purposes included in this collection of human biological samples at the Caen University Hospital center\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"823"}}